Impact of Family History of Haemophilia on Diagnosis, Management and Outcomes in Severe Haemophilia
The majority of patients presented without a family history of HA which led to a delayed diagnosis and treatment initiation.
Authors
- Isabel Rivas
- Olga Benítez (ORCID: https://orcid.org/0000-0002-2883-9049)
- Martin Olivieri (ORCID: https://orcid.org/0000-0001-6434-6244)
- María Teresa Álvarez Román (ORCID: https://orcid.org/0000-0003-3296-4288)
- Nadine G. Andersson (ORCID: https://orcid.org/0000-0001-6058-8350)
- Veerle Labarque (ORCID: https://orcid.org/0000-0002-5052-9274)
- Marloes de Kovel (ORCID: https://orcid.org/0000-0003-3521-1863)
- Susanna Ranta (ORCID: https://orcid.org/0000-0001-7854-0371)
- Ana Rosa Cid (ORCID: https://orcid.org/0000-0002-1193-9924)
- Ana Mendoza (ORCID: https://orcid.org/0009-0006-5248-8708)
Institutions
- Universitat Autònoma de Barcelona (ES)
- Karolinska University Hospital (SE)
- Lund University (SE)
- Hospital Universitario La Paz (ES)
- LMU Klinikum (DE)
- Sociedad Española de Trombosis y Hemostasia (ES)
- Vall d'Hebron Hospital Universitari (ES)
- Skåne University Hospital (SE)
- Vall d'Hebron Institute of Oncology (ES)
- Universidad Autónoma de Madrid (ES)
- Ludwig-Maximilians-Universität München (DE)
- KU Leuven (BE)
Publication Details
- Journal
- Haemophilia
- Published
- 2025-05-30
- DOI
- https://doi.org/10.1111/hae.70018
- Primary Topic
- Hemophilia Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer
- Bayer
- Sanofi
- CSL Behring
- Novo Nordisk